Annual Total Liabilities
$1.87 M
-$13.89 M-88.13%
December 1, 2023
Summary
- As of February 7, 2025, CYTO annual total liabilities is $1.87 million, with the most recent change of -$13.89 million (-88.13%) on December 1, 2023.
- During the last 3 years, CYTO annual total liabilities has fallen by -$2.74 million (-59.42%).
- CYTO annual total liabilities is now -91.14% below its all-time high of $21.12 million, reached on December 31, 2016.
Performance
CYTO Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$1.75 M
-$120.90 K-6.46%
June 1, 2024
Summary
- As of February 7, 2025, CYTO quarterly total liabilities is $1.75 million, with the most recent change of -$120.90 thousand (-6.46%) on June 1, 2024.
- Over the past year, CYTO quarterly total liabilities has dropped by -$7.18 million (-80.39%).
- CYTO quarterly total liabilities is now -93.39% below its all-time high of $26.50 million, reached on March 31, 2017.
Performance
CYTO Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
CYTO Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -88.1% | -80.4% |
| 3 y3 years | -59.4% | -88.9% |
| 5 y5 years | -70.4% | -88.9% |
CYTO Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -88.1% | at low | -88.9% | at low |
| 5 y | 5-year | -88.1% | at low | -88.9% | at low |
| alltime | all time | -91.1% | +113.0% | -93.4% | +112.2% |
Altamira Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $1.75 M(-6.5%) |
| Dec 2023 | $1.87 M(-88.1%) | $1.87 M(-79.0%) |
| Jun 2023 | - | $8.93 M(-43.4%) |
| Dec 2022 | $15.77 M(+134.9%) | $15.77 M(+39.3%) |
| Jun 2022 | - | $11.32 M(+68.7%) |
| Dec 2021 | $6.71 M(+45.5%) | $6.71 M(+69.4%) |
| Jun 2021 | - | $3.96 M(-14.1%) |
| Dec 2020 | $4.61 M(+40.1%) | $4.61 M(+25.9%) |
| Jun 2020 | - | $3.66 M(+11.3%) |
| Dec 2019 | $3.29 M(-47.9%) | $3.29 M(+15.6%) |
| Jun 2019 | - | $2.85 M(-55.0%) |
| Dec 2018 | $6.33 M(-69.2%) | $6.33 M(-29.4%) |
| Sep 2018 | - | $8.96 M(-18.9%) |
| Jun 2018 | - | $11.04 M(-38.8%) |
| Mar 2018 | - | $18.04 M(-12.1%) |
| Dec 2017 | $20.52 M | $20.52 M(-14.5%) |
| Sep 2017 | - | $24.01 M(-3.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | $24.83 M(-6.3%) |
| Mar 2017 | - | $26.50 M(+25.5%) |
| Dec 2016 | $21.12 M(+158.6%) | $21.12 M(-5.8%) |
| Sep 2016 | - | $22.42 M(+149.6%) |
| Jun 2016 | - | $8.98 M(+8.3%) |
| Mar 2016 | - | $8.29 M(+1.6%) |
| Dec 2015 | $8.16 M(+30.0%) | $8.16 M(-1.5%) |
| Sep 2015 | - | $8.29 M(-6.0%) |
| Jun 2015 | - | $8.82 M(+22.7%) |
| Mar 2015 | - | $7.19 M(+14.5%) |
| Dec 2014 | $6.28 M(-143.6%) | $6.28 M(-11.0%) |
| Sep 2014 | - | $7.05 M(+68.0%) |
| Jun 2014 | - | $4.20 M(-6.5%) |
| Mar 2014 | - | $4.49 M(-131.2%) |
| Dec 2013 | -$14.40 M(-1284.7%) | -$14.40 M |
| Dec 2012 | $1.22 M(+25.1%) | - |
| Dec 2011 | $971.80 K | - |
FAQ
- What is Altamira Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Altamira Therapeutics?
- What is Altamira Therapeutics annual total liabilities year-on-year change?
- What is Altamira Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Altamira Therapeutics?
- What is Altamira Therapeutics quarterly total liabilities year-on-year change?
What is Altamira Therapeutics annual total liabilities?
The current annual total liabilities of CYTO is $1.87 M
What is the all time high annual total liabilities for Altamira Therapeutics?
Altamira Therapeutics all-time high annual total liabilities is $21.12 M
What is Altamira Therapeutics annual total liabilities year-on-year change?
Over the past year, CYTO annual total liabilities has changed by -$13.89 M (-88.13%)
What is Altamira Therapeutics quarterly total liabilities?
The current quarterly total liabilities of CYTO is $1.75 M
What is the all time high quarterly total liabilities for Altamira Therapeutics?
Altamira Therapeutics all-time high quarterly total liabilities is $26.50 M
What is Altamira Therapeutics quarterly total liabilities year-on-year change?
Over the past year, CYTO quarterly total liabilities has changed by -$7.18 M (-80.39%)